Who owns Adaptimmune Therapeutics?

Top Holders and Investors of Adaptimmune Therapeutics Stock

Find out what company owns Adaptimmune Therapeutics, who bought Adaptimmune Therapeutics this quarter, and who sold shares of Adaptimmune Therapeutics stock?

Fund or Company Name Number of Shares Valued At As Of
Matrix Capital Management Company 28.00M $42.28M Sep 2019
NEA Management Company 15.83M $19.00M Dec 2019
Capital World Investors^ 6.79M $10.26M Sep 2019
Baillie Gifford & Co 4.29M $5.15M Dec 2019
Man 2.05M $3.09M Sep 2019
Fmr 1.58M $1.89M Dec 2019
Renaissance Technologies 1.47M $1.76M Dec 2019
OrbiMed Advisors 1.35M $2.04M Sep 2019
Millennium Management 914416 $1.38M Sep 2019
Rock Springs Capital Management 875000 $1.32M Sep 2019
Polygon Management 857311 $1.03M Dec 2019
Rathbones Brothers 702575 $843090 Dec 2019
Capital Research and Management Company - Division 3^ 627000 $946770 Sep 2019
Morgan Stanley 403461 $609226 Sep 2019
Name : WS Management 149507 $179408 Dec 2019
GSA Capital Partners 102894 $123472 Dec 2019
Wellington Management Company 83302 $99129 Dec 2019
Marshall Wace 79248 $119664 Sep 2019
Hambrecht & Quist Capital Management 77061 $116362 Sep 2019
Jpmorgan Chase & Co 76206 $90685 Dec 2019
Geode Capital Management 64000 $96000 Sep 2019
Goldman Sachs 35348 $53022 Sep 2019
Partnervest Advisory Services 35000 $42000 Dec 2019
CalPERS 30500 $36905 Dec 2019
Raymond James & Associates 29411 $34999 Dec 2019
D. E. Shaw & Co 26579 $39868 Sep 2019
Citadel Advisors 18962 $29011 Sep 2019
PanAgora Asset Management 18466 $21974 Dec 2019
KBC Group NV 5900 $7021 Dec 2019
UBS Group AG 5470 $24013 Mar 2019
Cutler 2700 $2997 Dec 2019
Rockefeller Capital Management 2000 $2000 Dec 2019
Royal Bank of Canada 2000 $3000 Sep 2019
Deutsche Bank Aktiengesellschaft 862 $999 Sep 2019
Wells Fargo & Company 800 $0 Sep 2019
Quantamental Technologies 700 $1001 Sep 2019
Barclays 526 $999 Dec 2019
NEXT Financial Holdings 475 $1999 Mar 2019
NEXT Financial 475 $1002 Dec 2019
Advisor 400 $0 Dec 2019
Tower Research Capital 162 $0 Dec 2019
Exane Derivatives 121 $536 Dec 2019
Advisory Services Network 100 $0 Dec 2019
Live Your Vision 66 $0 Mar 2019
Citi 20 $0 Dec 2019

Who sold Adaptimmune Therapeutics?

Fund Name Date Sold Shares Held Valued At
BlackRock Sept. 30, 2019 829567 $1.25M
Bam June 30, 2019 172669 $694129
Weiss Multi-strategy Advisers March 31, 2019 65000 $280150
A.R.T. Advisors March 31, 2019 24111 $103918
ProShare Advisors Sept. 30, 2019 22483 $33949
SG Americas Securities Sept. 30, 2019 21987 $32980
Aperio Sept. 30, 2019 19581 $29958
Raymond James Financial Services Advisors Sept. 30, 2019 18000 $27000
Steward Partners Investment Advisory Sept. 30, 2019 2000 $3000
Springbok Capital Management March 31, 2019 819 $3996
Glenmede Trust Company, N.A. Sept. 30, 2019 375 $0
Daiwa Securities Sept. 30, 2019 323 $0
Bank of America Corporation March 31, 2019 267 $1001
Simplex Trading Sept. 30, 2019 65 $0